生物医药系列产品
数据
资源
版本对比
免费注册
预约演示
免费注册
Diabetic Macular Edema
Pipeline Sees Expansion Owing to Key
2021-05-12
·
GlobeNewswire
合作
Los Angeles, USA, May 12, 2021 (GLOBE NEWSWIRE) --
Diabetic Macular Edema
Pipeline Sees Expansion Owing to Key Players, Key Therapies and Research & Programmes
Diabetic Macular Edema
Pipeline Insight report offers deep insights into emerging
Diabetic Macular Edema
pipeline therapies with an analysis of 50+key players and 50+key therapies. DelveInsight’s ‘
Diabetic Macular Edema (DME)
Pipeline Insights’ report provides a holistic view of the DME pipeline therapies that are under development in pre-clinical as well as clinical stages of development and growth prospects across the
Diabetic Macular Edema
landscape. Key takeaways of the
Diabetic Macular Edema
Pipeline report: Got queries? Want to know more? Request for Sample @
Diabetic Macular Edema
Emerging Therapies and Forecast
Diabetic Macular Edema
: Overview
Macular edema
is a condition characterized by the build-up of fluid in the macula, an area in the center of the retina. The excess build-up results in the swelling and thickening of the macula leading to distorted vision. It is referred to as
Diabetic Macular Edema (DME)
as it is caused by a complication of
diabetes
called
diabetic retinopathy
. For more information on emerging drugs, visit
Diabetic Macular Edema
Pipeline Analysis The DME pipeline report proffers a rich coverage of the therapeutics by development stage, product type, and route of administration, molecule type, and MOA type for
Diabetic Macular Edema
across the complete product development cycle, including all clinical and non-clinical stages.
Diabetic Macular Edema
Pipeline Drugs Request for Sample to know which drug is expected to outperform @
Diabetic Macular Edema
Pipeline Analysis, Key Companies, and Futuristic Trends
Diabetic Macular Edema
Therapeutics Assessment The
Diabetic Macular Edema
Pipeline report proffers exhaustive insights into active pipeline assets segmented by Stage, Product Type, Route of Administration, Molecule Type, Target, and Indications of various drugs. By Product Type By Stage By Molecule Type By Route of
Administration
By Mechanism of Action By Targets By Stage and Route of AdministrationBy Stage and Product Type Get in touch with our Business executive for
Rich
and Deep Market Assessment and Consulting Solutions The
Diabetic Macular Edema
pipeline report puts on the table business opportunities, threats, prospective collaborations, strong competitors, growth strategies, and failed as well as discontinued drugs that will help the clients to keep a track of the ongoing trials, recent happenings in the DME domain. Scope of the Report Coverage: GlobalKey Players:
Kodiak Sciences
,
Novartis Pharmaceuticals
,
Adverum Biotechnologies
,
KalVista Pharmaceuticals
,
Momenta Pharmaceuticals
,
Roche
,
Regeneron Pharmaceuticals
,
Exonate
,
Opthea Limited
,
SciFluor Life Sciences
,
AsclepiX Therapeutics
,
RemeGen
,
UNITY Biotechnology
,
Celltrion
,
Bio-Thera Solutions
,
Ripple Therapeutics
,
GrayBug Vision
,
Oxurion
,
Aerie Pharmaceuticals
,
GlaxoSmithKline
,
Boehringer Ingelheim
, and
Apexian Pharmaceuticals
among others.Key
Diabetic Macular Edema
Pipeline Therapies:
KSI 301
,
LKA651
,
ADVM-022
,
KVD001
, MYL-1701P,
Faricimab
, REGN 910-3,
EXN407
,
OPT-302
,
SF0166
,
AXT107
,
Brolucizumab
, RC28-E,
UBX1325
,
CT-P42
,
BAT5906
,
IBE-814
,
GB-102
,
THR-149
,
AR-13503
,
GSK2798745
,
BI 1026706
, and
APX3330
among others. Reach out how novel therapies are transforming the DME landscape @
Diabetic Macular Edema
Pipeline Table of Contents Visit to know more of what’s covered @
Diabetic Macular Edema
Emerging Therapies Related Reports
Chronic Pain
Associated With
Painful Diabetic Neuropathy
MarketDelveInsight's "
Chronic Pain
Associated with
Painful Diabetic Neuropathy
- Market Insights, Epidemiology, and Market Forecast-2030" report.
Diabetic Foot Ulcers
MarketDelveInsight’s ‘
Diabetic Foot Ulcer (DFU)
- Market Insights, Epidemiology, and Market Forecast—2030’ report. Diabetic Foot MarketDelveInsight's "Diabetic Foot - Market Insights, Epidemiology, and Market Forecast-2030" report.
Diabetic Eye Disease
MarketDelveInsight's "
Diabetic Eye Disease
- Market Insights, Epidemiology, and Market Forecast-2030" report.
Diabetic Ketoacidosis
MarketDelveInsight's "
Diabetic Ketoacidosis
(DKA) - Market Insights, Epidemiology, and Market Forecast-2030" report. Diabetic Gastroparesis Market SizeDelveInsight’s ‘Diabetic Gastroparesis (DGp) - Market Insights, Epidemiology and Market Forecast-2030’ report offers a detailed analysis of therapies and key pharmaceutical companies including
Allergan Evoke Pharma Inc.
,
Theravance Biopharma
,
Censa Pharmaceuticals
,
CinDome Pharma
, Takeda (Millennium Pharmaceuticals, Inc.),
Bird Rock Bio
, and others.
Diabetic Kidney Disease
MarketDelveInsight's "
Diabetic Kidney Disease (DKD)
- Market Insights, Epidemiology, and Market Forecast-2030" report. Related Posts Understanding The Increasing Prevalence Of
Diabetes
And Its Complications
Diabetic Peripheral Neuropathy
Market Landscape
Diabetic Peripheral Neuropathy
Medications About DelveInsight DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports
Pharma
companies by providing end-to-end comprehensive solutions to improve their performance. Get hassle-free access to all the healthcare and pharma market research reports through our subscription-based platform PharmDelve. For more insights, visit
Pharma
, Healthcare, and
Biotech
News
机构
Novartis Pharmaceuticals Corp.
Kodiak Sciences, Inc.
Boehringer Ingelheim GmbH
[+28]
适应症
糖尿病性黄斑水肿
黄斑水肿
糖尿病
[+9]
靶点
-
药物
Tarcocimab tedromer
LKA-651
Ixoberogene soroparvovec
[+17]
标准版
¥
16800
元/账号/年
新药情报库 | 省钱又好用!
立即使用
来和芽仔聊天吧
热门报告
特应性皮炎深度解析:药物开发、专利分析与风险评估
智慧芽生物医药
2024年7月全球首批及特殊审评药物报告
智慧芽生物医药
GPRC5D靶点专利调研报告
智慧芽生物医药
立即开始免费试用!
智慧芽新药情报库是智慧芽专为生命科学人士构建的基于AI的创新药情报平台,助您全方位提升您的研发与决策效率。
开始免费试用
立即开始数据试用!
智慧芽新药库数据也通过智慧芽数据服务平台,以API或者数据包形式对外开放,助您更加充分利用智慧芽新药情报信息。
试用数据服务